That could be the case cause that is the nature of the Bio-Pharma business. Things take time to work out and succeed. Well, unless we hear from more patent grant that is certainly beyond the control of the company.
I'm stoked with the Phase 1 news, but am I incorrect in my thinking that we might not get any news/progress for quite a stretch?
Yes, other products in various stages of development and/or clinical trials. Additionally, we could get updates on patents(IP) and JV announcements, new professional hires/consultancies, institutional investors, and lastly presentations at biopharma conferences.